Study Summary
This trial will test whether it is safe to forgo sentinel node biopsy (SNB) in older women with small, early-stage breast cancer.
- Breast Cancer
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 2 Secondary · Reporting Duration: From date of diagnosis until the date of death from any cause assessed up to 5 years.
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
Lumpectomy without sentinel node biopsy
1 of 1
Experimental Treatment
200 Total Participants · 1 Treatment Group
Primary Treatment: Lumpectomy without sentinel node biopsy · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 65+ · Female Participants · 5 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Is enrollment for this clinical research endeavor still open?
"According to clinicaltrials.gov, the recruitment for this research is still open. The announcement of the trial was made on January 22nd 2016 and it has been updated most recently on July 15th 2022." - Anonymous Online Contributor
What is the sample size of this trial's participants?
"Affirmative. Clinicaltrials.gov attests that this research endeavor launched on January 22nd 2016 and was amended lastly on July 15th 2022, is actively recruiting 200 participants from a single medical location." - Anonymous Online Contributor